Ascend Wellness Holdings (AAWH) Other Accumulated Expenses (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Other Accumulated Expenses came in at $9.0 million in Q1 2026, up 73.1% year-on-year from $5.2 million in Q1 2025, and up 27.41% quarter-over-quarter from $7.1 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses rose 73.1% year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 73.1% increase from a year earlier, with the FY2025 full-year figure at $7.1 million, up 39.72% from the prior year.
- Other Accumulated Expenses climbed to $9.0 million in Q1 2026 per AAWH's latest filing, from $7.1 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $9.0 million in Q1 2026 and bottomed at $4.1 million in Q1 2022.
- The 5-year median for Other Accumulated Expenses is $5.5 million (2023), against an average of $5.9 million.
- Across the five-year window, Other Accumulated Expenses slipped 29.4% in 2025 and jumped 73.1% in 2026, its largest moves.
- Year by year, Other Accumulated Expenses stood at $5.7 million in 2022, then rose by 18.41% to $6.8 million in 2023, then fell by 25.21% to $5.1 million in 2024, then surged by 39.72% to $7.1 million in 2025, then climbed by 27.41% to $9.0 million in 2026.
- Per Business Quant, the three latest AAWH Other Accumulated Expenses figures stand at $9.0 million (Q1 2026), $7.1 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 78.95 Mn | 18.03 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.01 Mn |
| Dec 31, 2025 | 7.07 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | 5.06 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 7.37 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 5.53 Mn |
| Mar 31, 2023 | 4.55 Mn |
| Dec 31, 2022 | 5.71 Mn |
| Sep 30, 2022 | 4.50 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 4.05 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 4.99 Mn |
| Jun 30, 2021 | 5.74 Mn |